Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

被引：45
|
作者：
Prebet, Thomas [1 ,2 ,3 ]
Gore, Steven D. [1 ,3 ]
Thepot, Sylvain [3 ]
Esterni, Benjamin [2 ]
Quesnel, Bruno [3 ]
Rauzy, Odile Beyne [3 ]
Dreyfus, Francois [3 ]
Gardin, Claude [3 ]
Fenaux, Pierre [3 ]
Vey, Norbert [2 ,3 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Hematol Malignancies, Baltimore, MD 21218 USA
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[3] Grp Francophone Myelodysplasies, Bobigny, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 06期
关键词：
Myelodysplasia; acute myeloid leukaemia; azacitidine; relapse; outcome; CONVENTIONAL CARE REGIMENS;
D O I：
10.1111/j.1365-2141.2012.09076.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 766
页数：3
相关论文
共 50 条
  • [41] Outcome of Patients With Myelodysplastic Syndrome After Failure of Decitabine Therapy
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Batty, Nicolas
    Shan, Jenny
    O'Brien, Susan
    Cortes, Jorge
    Ravandi, Farhad
    Issa, Jean-Pierre
    Kantarjian, Hagop
    CANCER, 2010, 116 (16) : 3830 - 3834
  • [42] Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Niessen, F. A.
    van Mourik, M. S. M.
    Bruns, A. H. W.
    Raijmakers, R. A. P.
    de Groot, M. C. H.
    van der Bruggen, T.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)
  • [43] Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome
    Tan, P.
    Wei, A.
    Mithraprabhu, S.
    Cummings, N.
    Liu, H. B.
    Perugini, M.
    Reed, K.
    Avery, S.
    Patil, S.
    Walker, P.
    Mollee, P.
    Grigg, A.
    D'Andrea, R.
    Dear, A.
    Spencer, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e170 - e170
  • [44] Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome
    P Tan
    A Wei
    S Mithraprabhu
    N Cummings
    H B Liu
    M Perugini
    K Reed
    S Avery
    S Patil
    P Walker
    P Mollee
    A Grigg
    R D'Andrea
    A Dear
    A Spencer
    Blood Cancer Journal, 2014, 4 : e170 - e170
  • [45] Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome
    Hughes, Charlotte F. M.
    Gallipoli, Paolo
    Agarwal, Rishu
    PATHOLOGY, 2021, 53 (03) : 328 - 338
  • [46] Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia
    Wiernik, Peter H.
    Sun, Zhuoxin
    Cripe, Larry D.
    Rowe, Jacob M.
    Fernandez, Hugo F.
    Luger, Selina M.
    Lazarus, Hillard M.
    Paietta, Elisabeth M.
    Tallman, Martin S.
    Litzow, Mark R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (02) : 309 - 318
  • [47] Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey
    Beguin, Y.
    Selleslag, D.
    Meers, S.
    Graux, C.
    Bries, G.
    Deeren, D.
    Vrelust, I.
    Ravoet, C.
    Theunissen, K.
    Voelter, V.
    Potier, H.
    Trullemans, F.
    Noens, L.
    Mineur, P.
    ACTA CLINICA BELGICA, 2015, 70 (01) : 34 - 43
  • [48] Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome
    F. A. Niessen
    M. S. M. van Mourik
    A. H. W. Bruns
    R. A. P. Raijmakers
    M. C. H. de Groot
    T. van der Bruggen
    Antimicrobial Resistance & Infection Control, 9
  • [49] Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome
    Fracchiolla, Nicola S.
    Iurlo, Alessanda
    Ferla, Valeria
    Fattizzo, Bruno
    Freyrie, Alessandra
    Reda, Gianluigi
    Cortelezzi, Agostino
    CLINICAL LABORATORY, 2017, 63 (09) : 1513 - 1517
  • [50] AzacitidineA Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia
    Gillian M. Keating
    Drugs, 2012, 72 : 1111 - 1136
12345